Keep yourself up to date with the latest checkpoint inhibitor news. This section includes updates on clinical trials, approvals, collaboration deals, and technology advancements on checkpoint inhibitor therapy.
News and Trends 15 Jun 2023
IOME Bio claims breakthrough in cancer research
IOME Bio, a French seed stage biotechnology company focused on overcoming tumor resistance to immune checkpoint inhibition, has published its foundational research by founders Arlene Sharpe and Dennis Kasper in Nature. The company said its work reveals unique insights into the critical importance of the RGMb/PD-L2 pathway in immunotherapy resistance and further strengthens the significance […]